Partnering & Outsourcing Editorial

  1. Igniting Innovation Through Global Collaboration: DIA 2022 5/17/2022

    DIA's Global Annual Meeting is the largest gathering of regulators, industry experts, healthcare practitioners, life science researchers, and patients. This June, DIA will bring this community to Chicago for an in-person meeting which promises to be a celebration and reunion.

  2. The Supply & Demand For Clinical Trial Staffing In 2022 & Beyond 5/5/2022

    The clinical trial staffing market is a high-margin market due to increasing numbers of clinical trials globally and high demand for resources. With the ongoing shortage of CRAs and those in other clinical operations roles, it is important for pharma companies to understand the current trends and how technology providers can help you tackle the attrition problem and manage the growing demand.

  3. How Small Biotechs Can Prepare For & Navigate CRO M&As 4/21/2022

    While mergers and acquisitions (M&As) are common in the life sciences industry, CRO-related M&As are happening at an accelerated rate. Small biotech companies may face short-term challenges if their current CRO partner goes through an M&A, but there are ways to mitigate the impact.

  4. 3 Best Practices For Actionable CRO Oversight 4/7/2022

    The ultimate purpose of sponsor oversight is to act when required. Audits, meetings, and documentation are not always enough. Too many sponsors seem to be forgetting that they are the customer; one that’s paying a heavy price for services that can ultimately make or break them. Reset the industry balance with these 3 best practices.

  5. How To Turn Your Clinical Supply Chain Pandemic Learnings Into New Best Practices 3/10/2022

    Pivoting, navigating, and problem solving in real time during the pandemic has led to many real-time lessons that have evolved into adapted best practices in the global clinical supply space. This article discusses the new demand curve, packaging operations, IRT considerations, and more.

  6. Your New 6-Step Approach For CRO Selection In 2022 2/15/2022

    Unfortunately, whether you’ve chosen the right clinical research organization (CRO) isn’t always obvious until contracts are signed and patients are enrolled. In 2022, basic industry standard steps are being skipped left and right. Here are 6 win-win suggestions to incorporate into your vendor selection strategy.

  7. Essential Elements Of Clinical Trial Sponsor Oversight For Mitigating Scientific Misconduct & Fraud 2/10/2022

    Sponsor companies are responsible for the protection of human subjects and the quality and integrity of their data when it comes to the conduct of clinical investigations. This responsibility sounds daunting, but this article shares how to break down key elements of CRO oversight in a holistic way.

  8. Is A Preferred Provider Agreement Right For You? 1/14/2022

    A preferred provider and/or a strategic provider is a vendor company, often a CRO or other specialty service provider, that has achieved priority status in the awarding of contracts by pharma/biotech companies. With the growing complexity of clinical research, the preferred provider is gaining popularity with many companies. Clinical Leader's Chief Editor, Ed Miseta, talks with Jennifer Johnson of UCB in this Q&A.

  9. How Biopharmas And CROs Can Create Value In Decentralized Global Trials 11/2/2021

    The need for biopharma execs to effectively engage CROs in decentralized clinical trials will only increase in the years to come. This article examines the results of a recent Ernst & Young (EY) study and also offers some recommendations for sponsors and CROs to be more effective with decentralized trials.

  10. Best Practices For Sourcing & Outsourcing In Clinical Operations 10/21/2021

    Transformation of clinical operations across processes, people, and technology has become a strategic priority, as nearly 70% of R&D spend is on clinical trials. Since a significant portion of clinical trials are outsourced to external partners, it is imperative that life sciences companies have a dependable set of global and regional external partnerships that are flexible and scalable.